JP2018536686A5 - - Google Patents

Download PDF

Info

Publication number
JP2018536686A5
JP2018536686A5 JP2018530000A JP2018530000A JP2018536686A5 JP 2018536686 A5 JP2018536686 A5 JP 2018536686A5 JP 2018530000 A JP2018530000 A JP 2018530000A JP 2018530000 A JP2018530000 A JP 2018530000A JP 2018536686 A5 JP2018536686 A5 JP 2018536686A5
Authority
JP
Japan
Prior art keywords
oxo
thia
dihydro
carboxamide
triazaacenaphthylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018530000A
Other languages
English (en)
Japanese (ja)
Other versions
JP6835846B2 (ja
JP2018536686A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/065954 external-priority patent/WO2017100662A1/en
Publication of JP2018536686A publication Critical patent/JP2018536686A/ja
Publication of JP2018536686A5 publication Critical patent/JP2018536686A5/ja
Application granted granted Critical
Publication of JP6835846B2 publication Critical patent/JP6835846B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018530000A 2015-12-10 2016-12-09 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物 Active JP6835846B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562265836P 2015-12-10 2015-12-10
US62/265,836 2015-12-10
PCT/US2016/065954 WO2017100662A1 (en) 2015-12-10 2016-12-09 Polycyclic compounds as inhibitors of bruton's tyrosine kinase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021016602A Division JP7072690B2 (ja) 2015-12-10 2021-02-04 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物

Publications (3)

Publication Number Publication Date
JP2018536686A JP2018536686A (ja) 2018-12-13
JP2018536686A5 true JP2018536686A5 (enExample) 2019-11-07
JP6835846B2 JP6835846B2 (ja) 2021-02-24

Family

ID=57681784

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018530000A Active JP6835846B2 (ja) 2015-12-10 2016-12-09 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物
JP2021016602A Active JP7072690B2 (ja) 2015-12-10 2021-02-04 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021016602A Active JP7072690B2 (ja) 2015-12-10 2021-02-04 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物

Country Status (30)

Country Link
US (5) US10717745B2 (enExample)
EP (2) EP3719022A1 (enExample)
JP (2) JP6835846B2 (enExample)
KR (1) KR102103395B1 (enExample)
CN (2) CN113121562B (enExample)
AR (1) AR107042A1 (enExample)
AU (1) AU2016366541B2 (enExample)
BR (1) BR112018011526B1 (enExample)
CA (1) CA3007990C (enExample)
CY (1) CY1123263T1 (enExample)
DK (1) DK3386991T3 (enExample)
EA (1) EA035168B1 (enExample)
ES (1) ES2805835T3 (enExample)
HR (1) HRP20201193T1 (enExample)
HU (1) HUE049502T2 (enExample)
IL (1) IL259863B (enExample)
JO (1) JO3794B1 (enExample)
LT (1) LT3386991T (enExample)
MA (2) MA43409B1 (enExample)
MD (1) MD3386991T2 (enExample)
ME (1) ME03803B (enExample)
MX (1) MX387590B (enExample)
PL (1) PL3386991T3 (enExample)
PT (1) PT3386991T (enExample)
RS (1) RS60604B1 (enExample)
SI (1) SI3386991T1 (enExample)
SM (1) SMT202000404T1 (enExample)
TW (1) TWI729047B (enExample)
UY (1) UY37015A (enExample)
WO (1) WO2017100662A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3794B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون
JO3793B1 (ar) * 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv مثبطات تيروزين كاينيز بروتون وأساليب استخدامها
TWI795381B (zh) 2016-12-21 2023-03-11 比利時商健生藥品公司 作為malt1抑制劑之吡唑衍生物
US20200079790A1 (en) * 2017-03-15 2020-03-12 Janssen Sciences Ireland Unlimited Company Methods of selective aryl- and heteroaryl-nitrogen bond formation
CN108164397B (zh) * 2018-01-18 2020-11-13 暨南大学 一类邻苯二酚衍生物及其制备方法
MX2020012204A (es) 2018-06-11 2021-03-31 Amgen Inc Inhibidores de kras g12c para tratar el cáncer.
MA55593A (fr) 2019-04-11 2022-02-16 Janssen Pharmaceutica Nv Cycles pyridine contenant des dérivés servant d'inhibiteurs de malt1
EP4089095A4 (en) * 2020-01-07 2024-03-27 Medshine Discovery Inc. DEUTERATED THIENOPYRIDINE COMPOUND
MX2023010314A (es) 2021-03-03 2023-11-24 Janssen Pharmaceutica Nv Terapia de combinación usando un inhibidor de malt1 y un inhibidor de btk.
BR112023025459A2 (pt) 2021-06-04 2024-02-27 Janssen Pharmaceutica Nv Inibidores da tirosina quinase de bruton e métodos de uso dos mesmos
CA3223610A1 (en) 2021-06-30 2023-01-05 Janssen Pharmaceutica Nv Inhibitors of bruton's tyrosine kinase and methods of their use
JP2024530204A (ja) 2021-08-09 2024-08-16 ヤンセン ファーマシューティカ エヌ.ベー. B細胞悪性腫瘍の治療に使用するための組成物
AU2023221549A1 (en) * 2022-02-18 2024-10-03 Janssen Pharmaceutica Nv Synthesis of bruton's tyrosine kinase inhibitors
WO2025262118A1 (en) 2024-06-20 2025-12-26 Janssen Pharmaceutica Nv Combination therapy using a malt1 inhibitor and a btk inhibitor

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3112415A1 (de) 1981-03-28 1982-10-07 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur chlorierung von cyclischen amiden und cyclischen vinylogen amiden
US5430150A (en) 1992-12-16 1995-07-04 American Cyanamid Company Retroviral protease inhibitors
US5300478A (en) 1993-01-28 1994-04-05 Zeneca Limited Substituted fused pyrazolo compounds
JP2008513463A (ja) 2004-09-15 2008-05-01 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ チアゾロピリジンキナーゼ阻害剤
WO2006118749A1 (en) 2005-05-04 2006-11-09 Janssen Pharmaceutica, N.V. Thia-tetraazaacenaphthylene kinase inhibitors
CN101277689B (zh) 2005-08-08 2011-01-12 詹森药业有限公司 噻唑并嘧啶类激酶抑制剂
US7427625B2 (en) * 2006-02-08 2008-09-23 Janssen Pharmaceutica, N.V. Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
PL2526933T3 (pl) 2006-09-22 2015-08-31 Pharmacyclics Llc Inhibitory kinazy tyrozynowej Brutona
US8598174B2 (en) * 2008-11-12 2013-12-03 Genetech, Inc. Pyridazinones, method of making, and method of use thereof
JP5739334B2 (ja) * 2009-08-26 2015-06-24 武田薬品工業株式会社 縮合複素環誘導体およびその用途
WO2011133609A2 (en) 2010-04-19 2011-10-27 The Translational Genomics Research Institute Methods and kits to predict therapeutic outcome of btk inhibitors
US20140249105A1 (en) 2011-07-25 2014-09-04 Diverchim Novel ceramide analogues, processes for preparing same and uses thereof
ES2924193T3 (es) 2013-03-15 2022-10-05 Janssen Pharmaceutica Nv Procesos e intermedios para preparar un medicamento
HRP20181109T1 (hr) * 2013-12-11 2018-11-02 Biogen Ma Inc. Spojevi biarila korisni za liječenje ljudskih bolesti u onkologiji, neurologiji i imunologiji
JO3793B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv مثبطات تيروزين كاينيز بروتون وأساليب استخدامها
JO3794B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون
WO2018103058A1 (en) 2016-12-09 2018-06-14 Janssen Pharmaceutica Nv Inhibitors of bruton's tyrosine kinase and methods of their use
WO2018103060A1 (en) 2016-12-09 2018-06-14 Janssen Pharmaceutica Nv Inhibitors of bruton's tyrosine kinase and methods of their use

Similar Documents

Publication Publication Date Title
IL259863A (en) Polycyclic compounds as inhibitors of bruton's tyrosine kinase
JP2021515033A5 (enExample)
JP2018536684A5 (enExample)
JP2019508467A5 (enExample)
JP2021524484A5 (enExample)
RU2015113746A (ru) Замещенные сульфонамиды
JP2019521109A5 (enExample)
JP2010512337A5 (enExample)
CN114787150A (zh) 炔基喹唑啉化合物
JP2022534261A5 (enExample)
JP2017505794A5 (enExample)
JP2018522847A5 (enExample)
JP2019505595A5 (enExample)
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
RU2012152354A (ru) Производные пирролопиразина в качестве ингибиторов syk и jak
HRP20171913T1 (hr) Aminopirimidinilni spojevi kao inhibitori jak
JP2024518792A5 (enExample)
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
JP2017511794A5 (enExample)
RU2014147191A (ru) Амидопроизводные как блокаторы ttx-s
RU2015116532A (ru) Ингибиторы тирозинкиназы syk
JP2021523941A5 (enExample)
JP2024536858A5 (enExample)
RU2017107521A (ru) Замещенные производные азетидина в качестве лигандов рецепторов следовых аминов taar
JP2015514679A5 (enExample)